PolyPid Ltd.

Yield per half year: +25.43%
Dividend yield: 0%
Sector: Healthcare

Company Analysis PolyPid Ltd.

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (77.02%) is higher than the sector average (-2.93%).

Disadvantages

  • Price (4.07 $) is higher than fair price (3.44 $)
  • Dividends (0%) are below the sector average (0.544%).
  • Current debt level 38.13% has increased over 5 years from 0%.
  • The company's current efficiency (ROE=-1038.73%) is lower than the sector average (ROE=109.03%)

Similar companies

Illumina

Amarin

Incyte

ImmunoGen

2. Share price and performance

2.1. Share price

2.3. Market efficiency

PolyPid Ltd. Healthcare Index
7 days 9.2% -13.4% -0.6%
90 days 27.6% -1.6% 2.9%
1 year 77% -2.9% 21%

PYPD vs Sector: PolyPid Ltd. has outperformed the "Healthcare" sector by 79.95% over the past year.

PYPD vs Market: PolyPid Ltd. has outperformed the market by 56.03% over the past year.

Stable price: PYPD is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.

Long period: PYPD with weekly volatility of 1.48% over the past year.

3. Summary of the report

3.1. General

P/E: -0.7026
P/S: 0

3.2. Revenue

EPS -4.91
ROE -1038.73%
ROA -142.99%
ROIC 0%
Ebitda margin 0%

5. Fundamental Analysis

5.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (4.07 $) is higher than the fair price (3.44 $).

Price is higher than fair: The current price (4.07 $) is 15.5% higher than the fair price.

5.2. P/E

P/E vs Sector: The company's P/E (-0.7026) is higher than that of the sector as a whole (-205.4).

P/E vs Market: The company's P/E (-0.7026) is higher than that of the market as a whole (-65.33).

5.3. P/BV

P/BV vs Sector: The company's P/BV (2.34) is lower than that of the sector as a whole (245).

P/BV vs Market: The company's P/BV (2.34) is lower than that of the market as a whole (50.62).

5.3.1 P/BV Similar companies

5.5. P/S

P/S vs Sector: The company's P/S indicator (0) is lower than that of the sector as a whole (61.67).

P/S vs Market: The company's P/S indicator (0) is lower than that of the market as a whole (138.73).

5.5.1 P/S Similar companies

5.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (-0.4626) is lower than that of the sector as a whole (12.25).

EV/Ebitda vs Market: The company's EV/Ebitda (-0.4626) is higher than that of the market as a whole (-48.34).

6. Profitability

6.1. Profitability and revenue

6.2. Earnings per share - EPS

6.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -5.74% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-5.74%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-609.67%).

6.4. ROE

ROE vs Sector: The company's ROE (-1038.73%) is lower than that of the sector as a whole (109.03%).

ROE vs Market: The company's ROE (-1038.73%) is lower than that of the market as a whole (-10.16%).

6.6. ROA

ROA vs Sector: The company's ROA (-142.99%) is lower than that of the sector as a whole (-2.42%).

ROA vs Market: The company's ROA (-142.99%) is lower than that of the market as a whole (40.05%).

6.6. ROIC

ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0.8343%).

ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (8.78%).

7. Finance

7.1. Assets and debt

Debt level: (38.13%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 0% to 38.13%.

Excess of debt: The debt is not covered by net income, percentage -33.14%.

7.2. Profit growth and share price

8. Dividends

8.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.544%.

8.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

8.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

9. Insider trades

9.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

9.2. Latest transactions

No insider transactions have been recorded yet

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription